Bank of New York Mellon Corp Has $994,000 Stock Holdings in iShares Biotechnology ETF (NASDAQ:IBB)

Bank of New York Mellon Corp trimmed its holdings in iShares Biotechnology ETF (NASDAQ:IBB) by 61.9% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 7,521 shares of the financial services provider’s stock after selling 12,219 shares during the period. Bank of New York Mellon Corp’s holdings in iShares Biotechnology ETF were worth $994,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds have also recently made changes to their positions in the company. HHM Wealth Advisors LLC raised its position in iShares Biotechnology ETF by 200.0% in the 4th quarter. HHM Wealth Advisors LLC now owns 225 shares of the financial services provider’s stock valued at $30,000 after buying an additional 150 shares during the last quarter. Newbridge Financial Services Group Inc. bought a new stake in shares of iShares Biotechnology ETF in the 4th quarter worth $33,000. Hager Investment Management Services LLC purchased a new stake in shares of iShares Biotechnology ETF in the fourth quarter valued at about $34,000. Modus Advisors LLC bought a new position in shares of iShares Biotechnology ETF during the fourth quarter valued at about $41,000. Finally, Crews Bank & Trust purchased a new position in iShares Biotechnology ETF during the fourth quarter worth about $44,000. 62.45% of the stock is currently owned by institutional investors and hedge funds.

iShares Biotechnology ETF Stock Up 1.3 %

Shares of NASDAQ IBB opened at $135.31 on Tuesday. The company has a market capitalization of $6.39 billion, a PE ratio of 27.83 and a beta of 0.84. The stock’s 50 day moving average price is $136.25 and its 200-day moving average price is $139.23. iShares Biotechnology ETF has a twelve month low of $123.60 and a twelve month high of $150.57.

iShares Biotechnology ETF Increases Dividend

The firm also recently announced a dividend, which was paid on Friday, March 21st. Stockholders of record on Tuesday, March 18th were given a dividend of $0.1212 per share. The ex-dividend date was Tuesday, March 18th. This is a positive change from iShares Biotechnology ETF’s previous dividend of $0.06.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.